Panem's five factors for company success

Panem's five factors for company successWhile the bear market has left many in the biotech industry feeling glum, there are still some strong supporters left among the buyside community.

BioCentury talked to Sandra Panem last week, after Vector Fund Management L.P. formally announced that she would become its managing partner in mid-August. Panem, who described herself as a "tremendous enthusiast of the industry," is leaving her post as portfolio manager of Oppenheimer Management Corp.'s Global Bio-Tech Fund(See BioCentury, July 11, 1994). She will oversee a planned $75 million fund that has received $40 million in formal commitments...